Brochure: Trusted iPSC Solutions for Toxicology
Fact Sheet: Ncyte® vCardiomyocytes
Scientific poster: Evaluation of human iPSC derived triculture as in vitro model for ...
The Solution to Non-Human Primate Research | Ncardia
.png)
User guide: Ncyte® Cardiac Fibroblasts
User guide: Ncyte® Microglia
Application note: Ncyte® Heart in a Box
Fact Sheet: Heart in a Box™
Fact Sheet: Ncyte® Microglia
Fact Sheet: Ncyte® aCardiomyocytes
Advancing High-Throughput Cardiac Screening With Physiologically Relevant 3D ...
.png)
Breaking New Ground in ALS Research
Ready-to-use iPSC-based assay to screen ALS therapeutics
Webinar: Human Hematopoietic Stem Cell Manufacturing from iPSCs
Catalyzing the Discovery of New Treatments for Proteinopathies
Mastering Consistency and Quality in iPSC-Derived Cell Manufacturing to Propel ...
Webinar: Transforming Gene Therapy with human in vitro models
Webinar: Beyond Symptom Relief - the Promising Future of NDD Drug Development with ...
Webinar: Alternative preclinical models to revolutionize cardiac and CNS drug ...
.png)
Webinar: Unlocking the secrets of muscular disease using iPSC models
The FDA Is Moving Past Animal Testing. Here’s How Ncardia Helps Make It Happen
Press release: Ncardia launches Ncyte® Microglia
Press release: Ncardia launches Ncyte® Heart in a Box
Press release: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target ...
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection ...
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
The Urgent Need for Reliable Cell Models in ALS Research
Ncardia @ ASGCT 24: The latest updates from Baltimore
Ncardia @ AD/PD 2024: The Latest In Alzheimer’s & Parkinson’s Research
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
